Cargando...

HER2/neu Immunostaining in Invasive Breast Cancer: Analysis of False Positive Factors

OBJECTIVES: HER2/neu gene amplification by Fluorescent in situ hybridization and protein expression by immunohistochemistry have been used for prognosis and guidance for the treatment of invasive ductal carcinoma of the breast with Trastuzumab. False positive results are a significant problem where...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Arafah, Maha, Kfoury, Hala K., Zaidi, Shaesta N.
Formato: Artigo
Idioma:Inglês
Publicado: OMJ 2010
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3191663/
https://ncbi.nlm.nih.gov/pubmed/22043354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5001/omj.2010.78
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!